NEWS FROM THE ECF

eCF Webinar November: FDA warning letters for audit trail analytics

Webinar November 2026

  • 28 October 2026
  • Author: Jana Summa
  • Number of views: 250
  • 0 Comments

Event date: 10/11/2026 10:00 - 11:00 Export event

eCF Webinar November 2026: FDA warning letters are telling you what to fix. Is your audit trail analytics listening? 

FDA warning letters name what went wrong. They rarely explain what a functioning audit trail analytics program should have caught instead.
This session works through a FDA warning letter in detail and uses it as a case study, tracing the inspection finding back through the data to identify where the analytical signal existed, why it was missed, and what a fit-for-purpose audit trail review program would have detected before the letter was written.

The goal is not to teach you about the letter, but to give you a method for reading any letter as a diagnostic for your own program. Attendees leave with a structured approach for connecting FDA inspection findings to audit trail analytics design, and a clearer picture of where their current programs may have the same blind spots.

The webinar will be held on Tuesday, November 10, 2026 and will take place twice. 

You can find more information and sign up here

Print
Tags:
Rate this article:
No rating
«November 2026»
MonTueWedThuFriSatSun
2627282930311
2345678
910

eCF Webinar November: FDA warning letters for audit trail analytics

FDA warning letters tell us what went wrong, but what could your audit trail analytics program have caught earlier? Join our upcoming webinar for a practical, in-depth look at an FDA warning letter and learn how to identify missed signals, uncover blind spots, and strengthen your audit trail review program.

Read more
1112131415
16171819202122
23242526272829
30123456